AdipoPharma
Developer of a peptide-based drug designed to offer treatment for patients suffering from type 2 diabetes. The company's drugs undergo a detailed analysis of the adipocyte's complex function, its intr...
Valuation
$18.4M
Market implied
Share Price
N/A
Total Raised
$34.5M
Last Round
Unknown
Latest Funding Round
Unknown
Investors
+11 other investors